Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Revenue: 2021-2024

Historic Revenue for Solid Biosciences (SLDB) over the last 4 years, with Dec 2024 value amounting to -$340,000.

  • Solid Biosciences' Revenue rose 25.74% to -$75,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$340,000, marking a year-over-year increase of 22.55%. This contributed to the annual value of -$340,000 for FY2024, which is 22.73% up from last year.
  • As of FY2024, Solid Biosciences' Revenue stood at -$340,000, which was up 22.73% from -$440,000 recorded in FY2023.
  • In the past 5 years, Solid Biosciences' Revenue registered a high of $13.6 million during FY2021, and its lowest value of -$440,000 during FY2023.
  • Moreover, its 3-year median value for Revenue was -$340,000 (2024), whereas its average is $2.4 million.
  • As far as peak fluctuations go, Solid Biosciences' Revenue tumbled by 105.44% in 2023, and later rose by 22.73% in 2024.
  • Over the past 4 years, Solid Biosciences' Revenue (Yearly) stood at $13.6 million in 2021, then plummeted by 40.57% to $8.1 million in 2022, then crashed by 105.44% to -$440,000 in 2023, then increased by 22.73% to -$340,000 in 2024.